Calvin Sandra's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Nov 6, 2025
- Accession no.
- 0001882909-25-000004
- Filed
- Nov 6, 2025
- Trade date
- Nov 4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 5 derivative transactions. Open-market sales total $2.42M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Calvin SandraCIK 0001882909 | Officer (SVP, CHIEF ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $25.25 | +$252,500 | 64,410 | Direct | |
| Nov 4, 2025 | Common Stock | MOption exerciseAcquired | +17,500 | $26.88 | +$470,400 | 81,910 | Direct | |
| Nov 4, 2025 | Common Stock | MOption exerciseAcquired | +15,000 | $27.50 | +$412,500 | 96,910 | Direct | |
| Nov 4, 2025 | Common Stock | MOption exerciseAcquired | +12,500 | $22.40 | +$280,000 | 109,410 | Direct | |
| Nov 4, 2025 | Common Stock | MOption exerciseAcquired | +6,250 | $8.93 | +$55,812.5 | 115,660 | Direct | |
| Nov 4, 2025 | Common Stock | SSaleDisposed | −67,115 | $36.00 | −$2,416,140 | 48,545 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Nov 4, 2025 | Common Stock | MOption exerciseDisposed | −17,500 | $0.00 | $0 | 0 | Direct | |
| Nov 4, 2025 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 2,500 | Direct | |
| Nov 4, 2025 | Common Stock | MOption exerciseDisposed | −12,500 | $0.00 | $0 | 7,500 | Direct | |
| Nov 4, 2025 | Common Stock | MOption exerciseDisposed | −6,250 | $0.00 | $0 | 18,750 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.